Statement of Paul E. Knierim Deputy Chief of Operations, Office of Global Enforcement Drug Enforcement Administration Before the Subcommittee on Border Security and Immigration Committee on the Judiciary United States Senate
The DEA Heroin Domestic Monitor Program (HDMP) is a retail-level heroin purchase program that provides data analysis about the geographic source of heroin along with price, purity, adulterants, and diluents sold at the street-level in 27 U.S. cities. The data in this report is from 2016.
Increasing numbers of teens are using prescription and over-the-counter medications to get high. Many parents and caregivers don’t know enough about this problem, and many teens don’t understand the dangers. Prescription for Disaster: How Teens Abuse Medicine is a guide that helps parents and caregivers understand and identify the medications teens are abusing. An invaluable resource for parents and caregivers, Prescription for Disaster: How Teens Abuse Medicine presents prescription drug basics, includes information about commonly abused prescription drugs, lists steps parents and caregivers can take to keep their teens drug free, and more.
Crafting initiatives and strategies to address opioid supply, demand, and misuse requires timely and actionable information and data, which this report endeavors to provide. This report presents a comprehensive assessment of the opioid crisis in Pennsylvania, through collection and analysis of supply and demand indicators and intelligence, as well as detailed county level analysis of multiple opioid misuse data sources.
The Drug Enforcement Administration’s Heroin Signature Program (HSP) analyzed several hundred wholesale-level heroin samples in 2016 to identify the geographic area where the samples were manufactured (Mexico, South America [SA], Southwest Asia [SWA], or Southeast Asia [SEA]).
The purpose of the Greater New Orleans Situational Drug Report is to identify current and emerging drug trends within the New Orleans metropolitan area as well as to deliver accurate and timely strategic intelligence to assist drug treatment and prevention organizations in the development of drug prevention and mitigation strategies. This assessment provides an overview of the region’s primary drug threats.
The 2018 National Drug Threat Assessment (NDTA) is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. The report combines federal, state, local, and tribal law enforcement reporting; public health data; open source reporting; and intelligence from other government agencies to determine which substances and criminal organizations represent the greatest threat to the United States.
Statement of Paul E. Knierim Deputy Chief of Operations, Office of Global Enforcement Before the Subcommittee on Africa, Global Health, Global Human Rights and International Organizations Committee on Foreign Affairs U.S. House of Representatives for a hearing entitled "Tackling Fentanyl: The China Connection"
This document is an internal Drug Enforcement Administration quality system document for latent print examination. The document is updated periodically and current as of August 13, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.
This Drug Enforcement Administration (DEA) Intelligence Report contains new and updated information on slang terms and code words from a variety of law enforcement and open sources, and serves as an updated version to the product entitled “Drug Slang Code Words” published by the DEA in May 2017. It is designed as a ready reference for law enforcement personnel who are confronted with hundreds of slang terms and code words used to identify a wide variety of controlled substances, designer drugs, synthetic compounds, measurements, locations, weapons, and other miscellaneous terms relevant to the drug trade. Although every effort was made to ensure the accuracy and completeness of the information presented, due to the dynamics of the ever-changing drug scene, subsequent additions, deletions, and corrections are inevitable. Future addendums and updates to this report will attempt to capture changed terminology to the furthest extent possible. This compendium of slang terms and code words is alphabetically ordered, with new additions presented in italic text, and identifies drugs and drug categories in English and foreign language derivations.
The Drug Enforcement Administration (DEA) New Jersey Division’s Intelligence Program conducted a bi-annual assessment of the drug threats occurring within the State of New Jersey between January and June 2017. This report highlights the strategic and significant findings regarding the illicit drug trends in the New Jersey Division’s (NJD) area of responsibility (AOR). Unless otherwise noted, data and findings are from DEA reporting.
Fentanyl is the most prevalent and the most significant synthetic opioida threat to the United States and will very likely remain the most prevalent synthetic opioid threat in the near term. The fentanyl threat remains most severe in the white powder heroin user market in the Midwest and Northeast United States, and fentanyl availability continues to be primarily by itself or with heroin. Fentanyl mixtures with non-opioid substances are a cause for public health concern due to the high potential for large numbers of fatal overdoses in short periods of time; however, there is no evidence that transnational criminal organizations (TCO) are trafficking strategic quantities of fentanyl already mixed with non-opioid drugs. Fentanyl’s popularity is unlikely to be challenged in the near term, but traffickers will likely continue to produce new fentanyl-related substances and other novel opioids.
In June and July 2017, law enforcement authorities made multiple undercover purchases of crack cocaine from one dealer in Baltimore, MD. In September 2017, official laboratory results indicated that two of these purchases tested as N-ethylpentylone Hydrochloride, a synthetic cathinone (“bath salts”) derivative classified as a Schedule I Controlled Substance Analogue.
As of October 2017, a review of Drug Enforcement Administration (DEA) National Forensic Laboratory Information System (NFLIS) data show that cocaine submissions indicate it is the number one seized substance by incident by law enforcement officials in South Carolina. The number of submissions has fluctuated with a high of 4,764 (in 2010) and a low of 3,492 (in 2012). The percent of cocaine submissions has declined every year since 2011 when compared to all South Carolina submissions.
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.